Prioritize the right biological targets

Empower your discovery biologists with the data, tools, and biomarkers they need to reduce early-stage uncertainty.

A close-up of a computer circuit board illuminated by blue lights, showcasing intricate electronic components.

Early discovery decisions ripple across your entire pipeline

Biologists set the direction of your drug program. Without clear biological context, your team risks advancing weak targets and missing opportunities, impacting timelines and costs. CAS BioFinder brings the information and tools needed to prioritize research paths, validate recommendations, and move forward confidently.

Curated literature that provides insights into biological relationships and interactions

Interconnected data revealing associations between biomarkers, diseases, and pathways for clearer understanding of disease mechanisms

Visualization tools that give pharmacological context to priority targets in early-stage research

3D rendered DNA double helix strand in translucent blue and pink against a background of floating transparent spheres and bubbles, representing genetic science and molecular biology

Make confident recommendations backed by dependable, interconnected data

From directing the team’s research paths to recommending targets for further investment, you need to be sure your decisions are based on clear, reliable information.

Because your team’s resources and reputation are at stake, CAS BioFinder structures, connects, and transforms biological evidence into actionable insights by combining the data and capabilities your team needs to bring clarity to early drug discovery.

CAS BioFinder advances discovery biology

Understand the mechanisms of a specific disease

Detailed biomarker tables, AI-generated biomarker summaries, filtering tools, and assay-linked references help biologists uncover disease mechanisms and identify key indicators for pathogenesis.

Deep dive into proteins associated with the disease of interest

Identify potential new targets and explore early signals of therapeutic potential with protein summaries, interactive 3D crystal structures, and detailed pathway diagrams that reveal biological function and therapeutic relevance.

Validate a target before passing it to the chemistry team

Confirm a target’s therapeutic value by exploring ligand-disease-target combinations by selectivity, potency, and toxicity predictions, and reviewing linked assay and pathway data.

Explore the untapped therapeutic potential of an approved drug

Harness drug intelligence dashboards, off-target interaction maps, and clinical trial links to uncover new indications and repurposing opportunities.

Zero in on the right targets

Discover how CAS BioFinder supports biologists at each step of the drug discovery workflow so you can confidently invest in the right direction and minimize downstream risk.

Download flyer